Skip to content

End-expiratory and End-inspiratory Occlusion Tests to Predict Fluid Responsiveness

End-expiratory and End-inspiratory Occlusion Tests to Predict Fluid Responsiveness in Mechanically Ventilated Cardiac Surgical Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03485833
Acronym
EEOFR
Enrollment
60
Registered
2018-04-02
Start date
2018-01-01
Completion date
2020-12-31
Last updated
2018-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery

Keywords

end-expiratory occlusion test, end-inspiratory occlusion test, transesophageal echocardiography, passive legs raising, fluid challenge

Brief summary

The purpose of the study is to verify the efficacy of using end-expiratory and end-inspiratory occlusion tests as an index of fluid responsiveness in mechanically ventilated patients with cardiac surgery.

Detailed description

Patients with hypotension after anesthetic induction for cardiac surgery, who requires fluid resuscitation based on clinical judgement by the anesthesiologists are enrolled in this study. Patients are monitored by transesophageal echocardiography and FloTrac/Vigileo. Hemodynamic variables (heart rate, systolic blood pressure, diastolic blood pressure, mean artery pressure, central venous pressure, stroke volume variation, cardiac index, velocity time integral of the aorta etc) are measured at baseline, after end-expiratory occlusion (EEO) test, after end-inspiratory occlusion (EIO) test, after passive legs raising test, and after fluid challenge respectively. Responders are defined by an increase in velocity time integral over 15% after infusion of 5ml/kg of crystalloid solution.

Interventions

DIAGNOSTIC_TESTEEO and EIO test

velocity time integral of the aorta measured by transesophageal echocardiography after end-expiratory and end-inspiratory occlusion test

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* cardiac surgical patients * hypotension after induction of anesthesia * required volume expansion by clinical judgement of the anesthesiologist

Exclusion criteria

* younger than 18 years * severe valve regurgitation or systolic dysfunction of the right ventricle * contraindication of the transesophageal echocardiography examination * cardiac arrhythmia * left ventricular ejection fraction less than 30% before surgery

Design outcomes

Primary

MeasureTime frameDescription
responderswithin 1 minute after volume expansionresponders are defined by volume time integral increases over 15% after volume expansion of 5ml/kg crystalloid

Secondary

MeasureTime frameDescription
nonresponderswithin 1 minute after volume expansionnonresponders are defined by volume time integral increases less than 15% after volume expansion of 5ml/kg crystalloid

Countries

China

Contacts

Primary ContactZhe Luo, PhD
luo.zhe@zs-hospital.sh.cn021-64041990

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026